Michela Deleidi
Otfried Müller. Str 27
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Peripheral Immune Challenge Drives Enteric α-Synuclein and Tau Pathology in LRRK2 G2019S Mice.
Journal: Aging and disease
Published: March 25, 2026
Toward actionable interventions in human aging (12th ARDD meeting, 2025).
Journal: Aging
Published: January 14, 2026
Engineering functional ventral midbrain dopaminergic neurons in human organoids through WNT modulation and bioreactor culture.
Journal: Molecular psychiatry
Published: October 21, 2025
Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models.
Journal: Journal of neuroinflammation
Published: May 30, 2025
New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.
Journal: The Lancet. Neurology
Published: October 18, 2024
The mitochondrial unfolded protein response in human microglia disrupts neuronal-glial communication and promotes senescence.
Journal: Nature neuroscience
Published: September 15, 2024
Emerging strategies, applications and challenges of targeting NAD+ in the clinic.
Journal: Nature aging
Published: August 27, 2024
LRRK2 Attenuates Antioxidant Response in Familial Parkinson's Disease Derived Neural Stem Cells.
Journal: Cells
Published: September 25, 2023
A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma.
Journal: Nature biomedical engineering
Published: August 09, 2023
New insights into the autophagy-NAD axis in brain disease.
Journal: Cell reports
Published: April 04, 2023
Glycolipids in Parkinson's disease: beyond neuronal function.
Journal: FEBS open bio
Published: March 13, 2023
Last Updated: 09/26/2026